Simplify Asset Management Inc. Ascendis Pharma A/S Transaction History
Simplify Asset Management Inc.
- $1.35 Billion
- Q2 2024
A detailed history of Simplify Asset Management Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Simplify Asset Management Inc. holds 8,877 shares of ASND stock, worth $1.09 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
8,877Holding current value
$1.09 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
225Shares Held
56.6MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.24 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$610 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$528 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$516 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$482 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $6.86B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...